NextCure Inc (NXTC)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE, MD 20705

NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases. Through its proprietary FIND-IO™ platform, NextCure studies various immune cells to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. Its initial focus is to bring hope and new treatments to patients who do not respond to current cancer therapies, patients whose cancer progresses despite treatment and patients with cancer types not adequately addressed by available therapies.

Data as of 2021-07-19 09:53:57 -0400
Market Cap199.619 Million Shares Outstanding27.61 Million Avg 30-day Volume347.39 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-11.73 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.28799 52-week High/Low14.4 / 7.1 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -13.4076
Data provided by IEX Cloud
View SEC Filings from NXTC instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 92 85 8.24% 31 (1.82%) 30 (1.74%) 3.33%
13F shares: 17.74 Million 17.218 Million 3.04% 10.597 Million 11.745 Million -9.78%
% Ownership 64.2771 62.4896 2.86% 38.3942 42.6271 -9.93%
New Positions: 19 20 -5.0% 7 8 -12.5%
Increased Positions 24 22 9.09% 9 6 50.0%
Closed Positions 12 11 9.09% 6 6 0.0%
Reduced Positions 33 29 13.79% 10 10 0.0%
Total Calls 171.813 Thousand 230.483 Thousand -25.46% 10.5 Thousand 0
Total Puts 308 Thousand 125.313 Thousand 145.78% 131.3 Thousand 58.6 Thousand 124.06%
PUT/CALL Ratio 1.79 0.54 231.48% 12.5 2214.81%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding NXTC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NXTC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KUNDU SOURAV SR VP, DEV. & MFG.

  • Officer
150,000 2021-07-15 2

WEBSTER STEPHEN W

  • Director
14,250 2021-06-24 1

KHUONG CHAU QUANG

  • Director
14,250 2021-06-24 1

KABAKOFF DAVID S

  • Director
14,250 2021-06-24 1

JONES ELAINE V

  • Director
14,250 2021-06-24 1

XU STELLA

  • Director
14,250 2021-06-24 1

NICHOLSON GARRY A

  • Director
14,250 2021-06-24 1

HOUSTON JOHN G

  • Director
14,250 2021-06-24 3

MAYER TIMOTHY CHIEF OPERATING OFFICER

  • Officer
100,000 2021-03-15 1

LANGERMANN SOL CHIEF SCIENTIFIC OFFICER

  • Officer
100,000 2021-03-15 1

LIU LINDA SVP, RESEARCH

  • Officer
100,000 2021-03-15 1

COBOURN STEVEN P. CHIEF FINANCIAL OFFICER

  • Officer
100,000 2021-03-15 1

RICHMAN MICHAEL PRESIDENT & CEO

  • Officer
  • Director
300,000 2021-03-15 1

MYINT HAN CHIEF MEDICAL OFFICER

  • Officer
0 2021-01-13 2

HELLER KEVIN N. CHIEF MEDICAL OFFICER

  • Officer
49,011 2020-07-14 0

MORRISON BRIGGS

  • Director
0 2020-06-11 0

LI JUDITH

  • Director
0 2020-06-11 0

BINGHAM JAMES B. CHIEF DEVELOPMENT OFFICER

  • Officer
0 2020-02-28 0

SOFINNOVA VENTURE PARTNERS IX, L.P.

SOFINNOVA MANAGEMENT IX, L.L.C.

HEALY JAMES

MEHRA ANAND

POWELL MICHAEL

  • 10% Owner
No longer subject to file 2019-11-15 0

SHANNON TIMOTHY M

  • Director
0 2019-06-13 0

CANAAN X L.P.

CANAAN PARTNERS X LLC

  • 10% Owner
No longer subject to file 2019-05-13 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

  • Director
  • 10% Owner
2,711,013 2019-05-13 0

ALEXANDRIA VENTURE INVESTMENTS, LLC

  • 10% Owner
No longer subject to file 2019-05-13 0

XU STELLA

QUAN VENTURE FUND II, L.P.

  • Director
  • 10% Owner
0 2019-05-08 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

KUNDU SOURAV - Officer SR VP, DEV. & MFG.

2021-07-19 16:07:10 -0400 2021-07-15 A 150,000 a 150,000 direct

KHUONG CHAU QUANG - Director

2021-06-28 18:09:31 -0400 2021-06-24 A 14,250 a 14,250 direct

NICHOLSON GARRY A - Director

2021-06-28 18:18:43 -0400 2021-06-24 A 14,250 a 14,250 direct

KABAKOFF DAVID S - Director

2021-06-28 18:15:22 -0400 2021-06-24 A 14,250 a 14,250 direct

XU STELLA - Director

2021-06-28 18:16:25 -0400 2021-06-24 A 14,250 a 14,250 direct

WEBSTER STEPHEN W - Director

2021-06-28 18:10:52 -0400 2021-06-24 A 14,250 a 14,250 direct

HOUSTON JOHN G - Director

2021-06-28 18:21:05 -0400 2021-06-24 A 14,250 a 14,250 direct

JONES ELAINE V - Director

2021-06-28 18:13:53 -0400 2021-06-24 A 14,250 a 14,250 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
NEXTCURE INC NXTC 2021-07-23 22:15:03 UTC -0.4147 0.4947 450000
NEXTCURE INC NXTC 2021-07-23 21:45:03 UTC -0.4147 0.4947 450000
NEXTCURE INC NXTC 2021-07-23 21:15:03 UTC -0.4147 0.4947 450000
NEXTCURE INC NXTC 2021-07-23 20:45:03 UTC -0.4147 0.4947 450000
NEXTCURE INC NXTC 2021-07-23 20:15:05 UTC -0.4147 0.4947 450000
NEXTCURE INC NXTC 2021-07-23 19:45:03 UTC -0.4147 0.4947 450000
NEXTCURE INC NXTC 2021-07-23 19:15:03 UTC -0.4147 0.4947 450000
NEXTCURE INC NXTC 2021-07-23 18:45:03 UTC -0.4147 0.4947 450000
NEXTCURE INC NXTC 2021-07-23 18:15:03 UTC -0.4147 0.4947 450000
NEXTCURE INC NXTC 2021-07-23 17:45:03 UTC -0.4147 0.4947 450000
NEXTCURE INC NXTC 2021-07-23 17:15:02 UTC -0.4147 0.4947 450000
NEXTCURE INC NXTC 2021-07-23 16:45:02 UTC -0.4147 0.4947 450000
NEXTCURE INC NXTC 2021-07-23 16:15:03 UTC -0.4147 0.4947 450000
NEXTCURE INC NXTC 2021-07-23 15:45:02 UTC -0.4147 0.4947 450000
NEXTCURE INC NXTC 2021-07-23 15:15:03 UTC -0.4147 0.4947 450000
NEXTCURE INC NXTC 2021-07-23 14:45:03 UTC -0.4147 0.4947 450000
NEXTCURE INC NXTC 2021-07-23 14:15:03 UTC -0.4147 0.4947 450000
NEXTCURE INC NXTC 2021-07-23 13:45:03 UTC -0.4147 0.4947 450000
NEXTCURE INC NXTC 2021-07-23 13:15:03 UTC -0.4147 0.4947 450000
NEXTCURE INC NXTC 2021-07-23 12:45:03 UTC -0.4147 0.4947 450000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Index Plus All-Cap Fund NXTC -17.0 shares, $-630.19 2020-03-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST- 361 Global Long/Short Equity Fund NXTC -17604.0 shares, $-154387.08 2021-04-30 N-PORT

Elevate your investments